A new, portable solvent extraction-based molybdenum-99/technetium-99m generator utilizing (n, γ) molybdenum-99 in sodium chloride solution for hospital radiopharmacy
Creators
- 1. RPL, Regional Centre, Board of Radiation and Isotope Technology, Variable Energy Cyclotron Centre, Kolkata (India)
- 2. Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai (India)
Description
Technetium-99m (99mTc, t1/2= 6.02 h; 140.51 keV (89%)) is the most important and useful radioisotope in diagnostic nuclear medicine. The methyl ethyl ketone (MEK)-based solvent extraction technique is a well-known method for the separation of 99mTc from low specific activity molybdenum-99 (99Mo). Here, we report a new, portable solvent extraction-based 99Mo/99mTc generator in tandem with alumina column utilizing (n,γ) 99Mo to produce highly purified, concentrated, clinical grade 99mTc. The pH of the aqueous solution of (n,γ) 99Mo (200-500 mCi) in dilute NaOH was adjusted to 7 and saturated with solid NaCl and then transferred to an extraction tube (50 ml) kept in the lead shielded arrangement. The pertechnetate (99mTcO4−) was selectively extracted in MEK and passed through two small alumina column (neutral alumina and acidic alumina). Finally, highly pure 99mTc was recovered from acidic alumina column with 3-5 ml saline in high concentration. The performance of this new 99Mo/99mTc generator was evaluated by studying the recovery yield of 99mTc, physicochemical tests, and radiolabeling with Tc cold kits such as methylene diphosphonate (MDP), diethylene-triamine-pentaacetate acid (DTPA) and sestamibi (MIBI). The average yield of separation of 99mTc was above 90% and 99Mo breakthrough in 99mTc pertechnetate was <0.0002% (n = 10). The final 99mTcO4- fraction has the Mo and Al content <10 ppm and MEK content <0.1% v/v, with radiochemical (RC) purity >99% and radionuclidic (RN) purity >99.9%. The efficacy of labeling specific compounds was assessed using standard radiopharmaceutical kits, such as 99mTc-MDP, 99mTc-DTPA, and 99mTc-MIBI, and RC purity was above 95% (n = 6). The newly developed portable 99Mo/99mTc generator can provide the highly concentrated and purified 99mTc-pertechnetate using low specific activity 99Mo and finds its application for hospital radiopharmacy. (author)
Additional details
Publishing Information
- Journal Title
- Indian Journal of Nuclear Medicine
- Journal Volume
- 32
- Journal Issue
- suppl
- Journal Page Range
- p. 17
- ISSN
- 0972-3919
Conference
- Title
- 49. annual conference of the society of nuclear medicine, India
- Acronym
- SNMI-2017
- Dates
- 14-17 Dec 2017
- Place
- New Delhi (India)
INIS
- Country of Publication
- India
- Country of Input or Organization
- India
- INIS RN
- 53016668
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- CLINICAL TRIALS; DTPA; METHYL ISOBUTYL KETONE; MOLYBDENUM 99; NEUROLOGY; PERTECHNETATES; RADIOPHARMACEUTICALS; TECHNETIUM 99
- Descriptors DEC
- AMINO ACIDS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; CARBOXYLIC ACIDS; CHELATING AGENTS; DAYS LIVING RADIOISOTOPES; DRUGS; EVEN-ODD NUCLEI; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; KETONES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; MOLYBDENUM ISOTOPES; NUCLEI; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; OXYGEN COMPOUNDS; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOPROTECTIVE SUBSTANCES; REFRACTORY METAL COMPOUNDS; RESPONSE MODIFYING FACTORS; TECHNETIUM COMPOUNDS; TECHNETIUM ISOTOPES; TESTING; TRANSITION ELEMENT COMPOUNDS; YEARS LIVING RADIOISOTOPES